These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38868363)

  • 1. LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation.
    Ali A; Grillone K; Ascrizzi S; Caridà G; Fiorillo L; Ciliberto D; Staropoli N; Tagliaferri P; Tassone P; Di Martino MT
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102221. PubMed ID: 38868363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.
    Nedaeinia R; Sharifi M; Avan A; Kazemi M; Rafiee L; Ghayour-Mobarhan M; Salehi R
    Cancer Gene Ther; 2016 Aug; 23(8):246-53. PubMed ID: 27364574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.
    Najafi Z; Sharifi M; Javadi G
    J Gastrointest Cancer; 2020 Mar; 51(1):109-115. PubMed ID: 30815771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.
    Tassone P; Di Martino MT; Arbitrio M; Fiorillo L; Staropoli N; Ciliberto D; Cordua A; Scionti F; Bertucci B; Salvino A; Lopreiato M; Thunarf F; Cuomo O; Zito MC; De Fina MR; Brescia A; Gualtieri S; Riillo C; Manti F; Caracciolo D; Barbieri V; Di Paola ED; Di Francesco AE; Tagliaferri P
    J Hematol Oncol; 2023 Jun; 16(1):68. PubMed ID: 37365583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer.
    Nedaeinia R; Avan A; Ahmadian M; Nia SN; Ranjbar M; Sharifi M; Goli M; Piroozmand A; Nourmohammadi E; Manian M; Ferns GA; Ghayour-Mobarhan M; Salehi R
    J Cell Biochem; 2017 Dec; 118(12):4129-4140. PubMed ID: 28401648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.
    Song Y; Zhao Y; Ding X; Wang X
    Am J Cancer Res; 2018; 8(3):435-449. PubMed ID: 29636999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
    Gao F; Wang W
    Mol Med Rep; 2015 Feb; 11(2):1200-6. PubMed ID: 25369914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.
    Liao D; Li T; Ye C; Zeng L; Li H; Pu X; Ding C; He Z; Huang GL
    Exp Ther Med; 2018 Feb; 15(2):1712-1717. PubMed ID: 29434757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer effects of miR-200c in colorectal cancer through BMI1.
    Karimi Mazraehshah M; Tavangar SM; Saidijam M; Amini R; Bahreini F; Karimi Dermani F; Najafi R
    J Cell Biochem; 2018 Dec; 119(12):10005-10012. PubMed ID: 30171714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.
    Christensen LL; Holm A; Rantala J; Kallioniemi O; Rasmussen MH; Ostenfeld MS; Dagnaes-Hansen F; Øster B; Schepeler T; Tobiasen H; Thorsen K; Sieber OM; Gibbs P; Lamy P; Hansen TF; Jakobsen A; Riising EM; Helin K; Lubinski J; Hagemann-Madsen R; Laurberg S; Ørntoft TF; Andersen CL
    PLoS One; 2014; 9(6):e96767. PubMed ID: 24892549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection.
    Torres AG; Fabani MM; Vigorito E; Gait MJ
    RNA; 2011 May; 17(5):933-43. PubMed ID: 21441346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer.
    Iyer DN; Foo DC; Lo OS; Wan TM; Li X; Sin RW; Pang RW; Law WL; Ng L
    BMC Cancer; 2022 Mar; 22(1):351. PubMed ID: 35361144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
    J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
    Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
    Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive
    Yasudome R; Seki N; Asai S; Goto Y; Kita Y; Hozaka Y; Wada M; Tanabe K; Idichi T; Mori S; Ohtsuka T
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression.
    Yu G; Xiong D; Liu Z; Li Y; Chen K; Tang H
    J Cell Biochem; 2019 Oct; 120(10):17258-17272. PubMed ID: 31104316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-103 promotes tumor growth and metastasis in colorectal cancer by directly targeting LATS2.
    Zheng YB; Xiao K; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN
    Oncol Lett; 2016 Sep; 12(3):2194-2200. PubMed ID: 27602163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNAs and lncRNAs serve as biomarkers for early colorectal cancer diagnosis.
    Lotfi E; Kholghi A; Golab F; Mohammadi A; Barati M
    Pathol Res Pract; 2024 Mar; 255():155187. PubMed ID: 38377721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats.
    Di Martino MT; Arbitrio M; Caracciolo D; Scionti F; Tagliaferri P; Tassone P
    Mol Ther Nucleic Acids; 2020 Jun; 20():73-85. PubMed ID: 32146420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer.
    Sastre D; Baiochi J; de Souza Lima IM; Canto de Souza F; Corveloni AC; Thomé CH; Faça VM; Schiavinato JLDS; Covas DT; Panepucci RA
    BMC Cancer; 2019 Dec; 19(1):1239. PubMed ID: 31864341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.